In view of recent discoveries of widespread exposure to fibrous minerals in several areas of the U.S. and globally, it is critical to evaluate rheumatologic manifestations in other cohorts so that screening, surveillance and diagnostic procedures are able to detect and recognize potential autoimmune outcomes of asbestos exposure.
Introduction
In the town and surrounding areas of Libby, Montana, decades of mining and widespread community use of asbestos-laden vermiculite led to both occupational and environmental exposures to a combination of mineral fibers now termed Libby Asbestiform Amphiboles (LAA). The health outcomes of these exposures that were reported among exposed individuals include both malignant and non-malignant pulmonary diseases, with a severe and progressive pleural fibrosis being the predominant pulmonary outcome Black, et al. 2014; Bunderson-Schelvan et al, 2011; Larson, et al. 2012; Lockey, et al. 2015; Peipins, et al. 2003; Whitehouse 2004; Whitehouse, et al. 2008 ). Due to the severity and extent of the asbestos-related disease (ARD) health impacts, Libby, along with the mine, was designated as an EPA Superfund site (Kuntz, et al. 2009; Noonan, et al. 2015; Winters, et al. 2012; . A nested case-control study of the Libby population screened by the Agency for Toxic Substances and Disease Registry (ATSDR), showed that past LAA exposure was associated with reported systemic autoimmune diseases (SAID) ). These observations led to further investigation of immunological responses to LAA exposure in both humans and animal models (Cyphert et al, 2012; . A high frequency of positive (and high titer) antinuclear autoantibody (ANA) tests were detected among patients and mice exposed to LAA (Ferro, et al. 2013; Pfau, et al. 2005; . Several other investigators also reported increased frequencies of ANA and rheumatoid factor among cohorts exposed to asbestos (reviewed in Pfau et al, 2014) .
Despite these lines of evidence suggesting an association between asbestos exposure and autoimmune responses, there is not a consensus among experts whether asbestos, particularly amphibole asbestos, needs to be added to the list of triggers for SAID, alongside silica (Noonan and Pfau 2011; Pfau et al 2014; Pfau 2017 : Miller, et al. 2012a 2012b) . Various investigators reported that this uncertainty is based upon the possibility that not all forms of asbestos drive an autoimmune response, and that autoimmune responses are seen more often with amphibole, rather than chrysotile, exposures (Ferro, et al. 2013; Pfau, et al. 2015; Pfau 2017) . Historically, chrysotile exposures have been prevalent due to extensive commercial use, but reductions in asbestos mining and product manufacturing are revealing that environmental asbestos exposures are abundant, often contain amphibole fibers, and exert adverse health impacts even at low levels of exposure (Baumann et al. 2013; Wolfe, et al. 2017; Bayram and Bakan 2014 , Buck, et al. 2013 , Lockey, et al. 2015 , Andujar et al, 2016 Lemen, 2016; Szeinuk, et al. 2017) . Therefore, the current study regarding LAA suggests that more research is needed regarding specific mineral fibers that may be triggers for SAID.
The limited epidemiological evidence supporting an association between asbestos exposure and autoimmunity is partially due to the complex case definition for rheumatological syndromes. Conditions that include a complex mixture of autoimmune systems and fail to meet clinical diagnostic criteria may be missed by surveillance and screening efforts. Anecdotally, physicians working with the Libby population perceived a high frequency of rheumatoid conditions that were not being diagnosed because signs and symptoms failed to meet strict diagnostic guidelines. Therefore, two of the objectives of the Libby Epidemiology Research Program (ATSDR) were to a) determine whether a unique rheumatological syndrome existed among LAA-exposed cohort, and b) characterize the population serologically and clinically for rheumatological conditions. The current report focused on this characterization by describing cases of clinical autoimmune outcomes in the LAA-exposed cohort. Our objective was to better understand the complex clinical nature of autoimmune outcomes related to fibrous amphibole exposure.
Materials & Methods

Cohort For Cases Identification
The Libby Epidemiology Research Program (LERP) cohort was restricted to current or former residents of the cities of Libby and Troy, Montana, ensuring that all subjects had been exposed to LAA. All subjects were 18 years or older, with no restriction regarding sex, smoking history, or medical diagnosis. Recruiting included local newspapers and word-of-mouth, in addition to recruitment through the health screening program at the Center for Asbestos Related Diseases (CARD) in Libby. Following informed consent, all subjects completed extensive medical history questionnaires and provided a blood sample for serum collection by standardized methods. The entire research protocol of the LERP was approved by the Icahn School of Medicine Institutional Review Board, New York, and the Providence Health Care Institutional Review Board, Spokane, Washington. Chart reviews were performed by IRB-approved research team members, and diagnoses were verified by obtaining confirmation of diagnosis or treatment.
The health screening program at the CARD currently contains 6,603 patient records. Of those, 13.8% have a diagnosis for an autoimmune disease other than diabetes. This database was used to construct Table 1, providing prevalence values for autoimmune diseases in Libby compared to published expected prevalence values in the United States.
Autoantibody Testing
All serum samples were collected at the CARD clinic by standardized protocols in serum separator tubes, and serum was stored at -80 o C until use. All samples were deidentified and given a research number. For patients seen at the CARD, ANA/ENA screening was performed at Pathology Associates Medical Laboratory (PAML) in Spokane, WA. A reflexive ANA screen was performed by ELISA, and if positive, a multiplex (Luminex) bead assay tested for 11 autoantibodies (dsDNA, Smith, Ribosomal P, Chromatin, RNP, SmRNP, Scl-70, Centromere B, SSA, SSB and Jo-1). All data were reported by PAML as positive/negative, with titers and values where appropriate. For patients seen by the rheumatologist (RD), testing was conducted at the Mayo Clinic (Mayo Medical Laboratories, Rochester, MN).
In addition, Indirect Immunofluorescence for ANA was performed at Idaho State University (JP) as previously described (Pfau, et al. 2005) . Briefly, samples were diluted at 1:40 in phosphate buffered saline, and then placed on wells of commercial ANA slides from ImmunoConcepts (Sacramento, CA). Following incubation, slides were washed and then the secondary antibody (anti-human IgG FITC conjugate) was added to each well. After incubation, washing and cover-slipping, slides were viewed by two blinded readers using a Leica upright fluorescence microscope, and compared against positive controls provided with the slides. Patterns and brightness were evaluated as negative or positive, with positives given a score of 1-4 based on staining intensity. If positive, the samples were titered.
Questionnaire Data
The CARD used an extensive questionnaire, covering exposure pathways (both occupational and environmental), family history, medical history, and symptoms. The responses were entered into a coded Access database for research access.
Case Descriptions
Cases were selected by research team physicians (BB, RD) that represent some of the unusual presentations of severe autoimmune disease noted in a concentrated population. A summary of the demographics in this case series is presented in Table 2 . All of these cases had relatively high LAA exposure, based upon an extensive exposure matrix (Noonan 2006; Noonan, et al. 2015) , with most of them being environmental (not occupational). Most of the cases had lifelong exposures, having grown up in the Libby area, and most developed symptoms in their 30's and 40's, but symptom onset ranged from 20 to 69 years old. The later onset cases (#4 and #7) were also older when first exposed ( Table 2 ). All of these cases have some form of pulmonary asbestos-related disease. Most are life-long non-smokers.
Although SAID are generally more common in females, in the Libby population, at least half or more of ANA positive subjects were male in randomly selected population subsets in previous studies (Pfau, et al. 2005; . This could reflect the broad, environmental nature of the exposures throughout the community. Based on rheumatology medical histories, many of the cases exhibited atypical presentations of SAID, sometimes in combinations, and with symptoms and diagnoses changing over time. Finally, occurrences of spouses who both have SAID diagnoses were observed in this population (illustrated here as Cases 2 & 3), an infrequent observation that is suggestive of an exposure-related manifestation of the symptoms.
Case # 1 -Urticarial Vasculitis
Currently 58 years old, this patient has been a Libby resident his entire life. He manages a local retail business and is married with grown children. He does not have any family history of arthritis or rheumatism and has been a life-long nonsmoker. The patient has experienced multiple pathways of LAA exposure, including growing up in a home in Libby, MT with vermiculite insulation in the attic and crawl space. His father's primary occupation was logging, which is a documented pathway of LAA exposure due to fiber accumulation in trees, including secondary home exposure as dust is brought home on clothing. He was also exposed to LAA by delivering auto parts to, and taking inventory at, the vermiculite mine site while it was in operation outside of Libby. He played in ore piles as a child and on baseball fields that were surfaced with LAA-containing material. He also reports heavy recreation in the Rainy Creek area for over 20 years. Rainy Creek is the drainage located below the mine site that has significant contamination from mine tailings. He was also a volunteer firefighter for 26 years, which might contribute to exposure when buildings, insulated with the vermiculite, burn and release LAA fibers into the ambient air.
This patient was first seen at the Center for Asbestos Related Disease (CARD) for asbestos health screening in mid-2011. He was asymptomatic at the time and diagnosed with smooth, lamellar pleural thickening identified on CT scan. The radiographic description of this type of pleural disease has been described elsewhere Szeinuk, et al. 2017 ). His initial pulmonary functions were within the normal range in 2015 with FVC recorded as 103% and DLCO 106%.
The patient began developing autoimmune symptoms of recurrent bouts of hives. The hives originally were treated with OTC antihistamines and after a few years, he was seen by a rheumatologist in 2000. Numerous lab tests revealed a low titer ANA at 1:40, but the remainder of the blood tests including rheumatoid factor, CCP, ANCA, complement and cryoglobulins were negative. Patient was instructed to continue with the antihistamines and cimetidine, but did not take them on a daily basis. The hives continued to recur and tended to be around his wrists and ankles, which also caused pain and swelling in his joints. He would have attacks every 4-6 weeks which would last anywhere from two to three days. By 2003, he was beginning to require steroids to control the joint pain and swelling that occurred in his peripheral joints, usually his wrists and ankles. The joints were aspirated and no gout crystals He began developing podagra symptoms and was diagnosed with gout and placed on allopurinol and colcrys with good control of pain and swelling. The patient remained on methotrexate with good control of the urticarial vasculitis. Occasionally, he takes prednisone if colchicine does not control the joint pain. The remainder of the review of systems for other autoimmune diseases has been negative.
Case #2 -Rheumatoid Arthritis
This patient is currently 57 years old and has been a Libby resident her entire life. She worked in a pharmacy and was a stay-at-home parent to two children. She does not report any family history of autoimmune disease, and she has been a lifelong nonsmoker. Her LAA exposure began as a child when she was raised in a home with vermiculite insulation, and her father, who was a vermiculite mine worker, brought dust home on his clothing. She reports multiple environmental exposures, including gardening in soil contaminated with Libby vermiculite and recreating in the Rainy Creek drainage area over many years.
She was first seen at the CARD in 2009 for asbestos health screening when she was asymptomatic and not diagnosed with ARD. She returned for repeat screening in 2010 at which time she was diagnosed with diffuse pleural thickening on CT scan, and she started to report respiratory symptoms. She was last seen in 2014 at which time she reported having trouble with a chronic cough, wheeze, chest tightness and shortness of breath. Her pulmonary function was normal in 2001 with FVC 100%, TLC 102%, DLCO 110%, and remained quite stable over time.
The patient described rheumatoid arthritis symptoms in 2007, and was diagnosed with rheumatoid arthritis by a rheumatologist in 2009 with joint swelling and fatigue. X-rays revealed no erosions. The patient was on prednisone daily for rheumatoid arthritis and failed many DMARD agents, including methotrexate, plaquenil and sulfasalazine. In 2012, she began treatment with actemra at 4 mg/kg which was then increased to 8 mg/kg every 4 weeks IV dosing, with methotrexate 25 mg subcutaneous and prednisone 5 mg daily. She did not go into remission. The patient was tried on Orencia, but developed headaches and discontinued the Orencia. The patient began Xeljanz in November 2013 for ongoing synovitis, and a Vectra DA 49 test was conducted in November 2013. The results were reported as greater than 45, revealing inflammation. The remainder of the review of systems for other autoimmune diseases was negative.
Case #3 -Rheumatoid Arthritis with Pleurisy
This patient is currently 60 years old and was a Libby resident his entire life. He worked in various service industries in the area including as a delivery truck driver. He is married with grown children. He does not have any family history of autoimmune disease and has been a lifelong nonsmoker. The patient's LAA exposure occurred throughout his lifetime. 
Case # 4 -Rheumatic Symptoms with Pleural and Interstitial Disease
The patient is currently 77 years old and never lived in Libby. He worked operating and renting heavy equipment for most of his career and is married. He reports no family history of autoimmune disease, and has a 12-pack year smoking history. He stopped smoking at age 39. His LAA exposure was from 1974 to 2003 when he worked full-time in a building in Kalispell, MT with vermiculite insulation. He had the vermiculite tested and it was identified to contain > 5% asbestos content. He reports that this insulation had spilled into his warehouse area, and that he cleaned it up regularly. 
Case #6 -Psoriatic Arthritis and Chronic Lymphocytic Leukemia
Patient is 58 years old and lived in Libby his whole life. He is married with one child.
He worked 9 years in the lumber industry, 22 years in construction and volunteered for the local fire department for over 20 years. He quit work in 2009 and went on disability primarily due to joint problems. Patient reports 26 pack years of smoking history and stopped when he was 48 years old. He also reports a family history of arthritis and psoriasis but is not certain of the exact diagnosis. The patient's LAA exposure began in his early childhood. His father owned and operated a local tire shop and gas station. This business serviced vehicles that were often contaminated with vermiculite dust containing LAA fibers and therefore carried into the home on his father's clothing. There was also a three-year period where the patient's older brother, still living at home, worked as a mechanic at the vermiculite mine. The patient reports having spent significant time in the Rainy Creek area, at least 12 years of time playing in or watching games at the downtown ball fields and playing in piles of the vermiculite ore.
The patient was first seen at the CARD in 2010 when he reported that he may be experiencing some dyspnea on exertion and was significantly limited by his arthritis. This is reported to have troubled him over the previous 4-5 years. 
Case #7 -Polymyalgia and Rheumatoid Arthritis with Pleurisy
Patient is currently 76 years old and was a resident of Libby, MT since the age of 27.
He is married with three grown children. He is a retired school teacher and has been self- Over time the patient's pulmonary function showed a decline in DLCO (66%). The patient was diagnosed with polymyalgia rheumatica in 2000 and placed on prednisone. In 2001, he developed swelling in his peripheral joints, hands, wrists, ankles and feet and was diagnosed with seronegative rheumatoid arthritis with negative serology labs, negative ANA, negative rheumatoid factor, negative CCP. X-rays revealed no erosions. He was placed on methotrexate with prednisone, but after 6 months, developed hair loss and oral ulcers, and methotrexate was discontinued. He was placed on leflunomide, did well with leflunomide and was able to taper off the prednisone. He was taking leflunomide for 1-l/2 years, but then started developing fluid around his heart and leflunomide was discontinued. The patient then 
Case #8 -Rheumatoid Arthritis with Pleural Fibrosis
Patient is currently 55 years old and was a resident of Libby, MT since the age of 6. He is married with two grown children. He worked in a retail business for over 30 years. He reports both parents having been diagnosed with ARD. Only one of his three siblings has been seen at the CARD, and he has also been diagnosed with an asbestos-related disease. The patient denies any family history of autoimmune disease. He reports being a lifelong nonsmoker. The patient has experienced multiple pathways of LAA exposure beginning in 1968 when his family moved to Libby, MT. Their first home in the area was remediated for LAA by the EPA after many years of living there. His father was a lumber mill worker for three years, starting when the patient was 9 years old. His father was exposed to dust from contaminated logs and would return home in clothing carrying the LAA fibers as dust. His father also coached sports, spending a lot of time around the ball fields and tracks that were surfaced with LAA-containing material. The patient played most sports in school, placing him at these ball fields and tracks. He does recall spending time playing in or around the vermiculite ore piles. As he got older, he rode 4-wheelers in the vermiculite piles and hunted around the entire mine site. His family spent many years collecting and burning firewood from the Rainy Creek area. Wood from this area contains the LAA fibers in the bark (Ward, et al. 2006; . His family also gardened with vermiculite ore, which his father brought home.
The patient was first seen at the CARD for asbestos health screening in late 2010. At that time, he reported increasing dyspnea on exertion and that he was experiencing bilateral posterolateral chest discomfort. He did not report a cough or wheeze. On completion of his screening CT, the patient was diagnosed with bilateral pleural thickening in the lower chest posteriorly, which was thin, lamellar and non-calcified. This is consistent with asbestosrelated disease. His pulmonary function test at this time resulted in a FVC of 83%, DLCO at 116%, TLC at 88% and RV at 91% of predicted. When compared to a spirometry assessment He was in the military but did not work below deck on ships. He drove a log truck for about a year and then worked installing satellite TV and lines where he was exposed to insulation in attics and basements. He is a current smoker with a 29 pack year history, and was first seen at CARD and diagnosed with asbestos-related pleural disease in 2013. He has a chronic cough in the mornings and feels left side chest congestion. He experiences pain in his posterior chest and has been using a Fentanyl patch for pain management. 
Discussion
Our overall objective with this study was to describe cases of patients whose medical history represented rheumatological clinical profiles of a cohort from Libby, Montana, with exposures to Libby Asbestiform Amphiboles (LAA) in order to characterize and improve recognition of autoimmune outcomes attributed to exposure. Previously, investigators demonstrated elevated frequency and titers of ANA in the Libby population, as well as an increased risk for self-reported SLE, SSc and RA Pfau, et al. 2005; .
The most common autoantibodies were to dsDNA (specific to both chromatin and histone), Ro-52, and Scl70, with some RNP or Sm (Pfau, et al. 2009 ). Antibodies associated with RA (CCP and rheumatoid factor) are rarely seen in this population (Pfau, et al. 2005; , but the prevalence for RA diagnoses is well above expected levels in the United States general population (Table 1) . CCP-and RF-positive RA is associated with early and rapidly progressive RA, often associated with smoking (Lingampalli, et al. 2018; Shafrin, et al. 2018; Pfau 2012.) Interestingly, exposure to asbestiform amphiboles also increased the frequency of positive ANA tests in non-autoimmune prone mice and rats (Ferro, et al. 2013; Pfau, et al. 2008; ). Mice exposed to tremolite, a component of LAA (Meeker, et al. 2003) , exhibited positive ANA tests (primarily dsDNA and Ro-52), immune complex deposition in the kidneys and mild glomerular changes suggestive of lupus nephritis . Amosite, also a component of LAA, was also shown to induce ANA in rats . However, exposure to these fibers in two rat models of arthritis failed to significantly elevate indicators of disease ). Noonan, et al (2006) reported a case-control study of self-reported RA, SLE and SSc patients, nested within a medically screened general population cohort in Libby, MT, where extensive exposures to a mixture of asbestiform amphiboles occurred. Data showed more than 4-fold enhanced risk associated with a history of greater LAA exposure via multiple environmental pathways . Since that time, 6603 patients have undergone health screening at the CARD, 387 (6.0%) having been diagnosed with rheumatoid arthritis, 67 with SLE, 47 with sarcoidosis, and 10 with scleroderma (Table 1) . Based upon published prevalence values for these diseases in the United States, all 4 diseases occur in Libby at higher than expected frequency. Prevalence in Libby of other diseases, including multiple sclerosis, ankylosing spondylitis and psoriatic arthritis were not different from expected.
These data, combined with the animal model studies, present strong evidence that LAA increases the risk for SAID.
However, as physicians (RD, BB) working with LAA-exposed patients, it was noted that there were many cases of a rheumatological clinical profile that were not being diagnosed due to failure to meet the current diagnostic criteria, or that presented with unusual combinations.
Symptoms included severe (prolonged) fatigue, Raynaud's phenomenon, rashes, swollen painful joints, and musculoskeletal pain. Although many of the patients also suffer from pulmonary abnormalities indicative of ARD, it is generally not interstitial disease Peipins, et al. 2003 ), but rather a thin lamellar pleural thickening Szeinuk, et al. 2017) . The purpose of this case series was to describe a small sample of people who presented with asbestos-related diseases and autoimmune disease. Pulmonary manifestations are known to occur in patients with SAID. These include various forms of pulmonary pneumonia (infectious, inflammatory and fibrotic), pleural effusions, vasculitis, alveolar hemorrhage, interstitial fibrosis, and obstructive pulmonary disease. Recently, there have been reports of cases of "shrinking lung syndrome" particularly associated with SLE, which manifests as progressive exertional dyspnea, pleuritic chest pain, and restrictive patterns on pulmonary function tests (PFT) (Borrell, et al. 2016; Duron, et al. 2016) . However, in the Libby cohort, pulmonary disease (lamellar pleural thickening) is more likely to be associated with asbestos exposure, making the presence of SAID unlikely to be the etiological explanation for the lung disease.
The immunotoxicity of asbestos begins with inflammation, driven by oxidative stress and cytokine production, and the mechanism of autoimmunity may be similar to that proposed for silica, which includes activation of self-reactive B cells by highly activated antigen presenting cells (Cooper, et al. 2008) . The effects of asbestos in mice and cell culture studies include "frustrated phagocytosis", oxygen radical formation, inflammasome activation, DNA damage, and apoptosis (Bunderson-Shelvan, et al. 2011; Hillegass, et al. 2013; Kodavanti, et al. 2014.) As with silica, mast cells may play a role in initial steps in asbestos autoimmune pathogenesis, since they are activated by asbestos fibers and are involved in the pathogenesis of both allergic and autoimmune diseases (Borelli, et al. 2018; Siebenhaar, et al. 2018.) . These early interactions of cells with mineral fibers appear to drive the ultimate disease outcomes, and may be related to specific size, mineralogy, and chemistry of the fibers. In order to work toward therapeutic modalities, further research is needed regarding specific mechanisms driving alterations of self-peptides that make them antigenic, leading to production of autoantibodies.
Conclusions
In conclusion, the cases described here suggest that there is not one underlying autoimmune disease associated with LAA exposure, but rather a large number of clinical presentations exist among this exposed cohort. They represent severe manifestations of different rheumatological conditions in a highly concentrated population, and this is unusual.
In addition, some of the cases demonstrate atypical presentations of SAID, sometimes in combinations, with symptoms and diagnoses changing over time. In many of these patients, it takes years for the final diagnosis to develop, and the evolving nature of the rheumatological symptoms may be quite unusual. Finally, these patients present with pulmonary comorbidities that complicate their clinical picture. Therefore, there are challenges for detection and diagnosis that may mean that the frequency of SAID associated with asbestos exposure may be under-reported.
Data suggest that exposure to LAA increases the risk of connective tissue disorders and that this requires further study and increased awareness among the rheumatology community. In view of recent discoveries of widespread exposure to similar amphibole fibers in several states (Buck, et al. 2013; Noonan 2017) , it is important to understand more about rheumatologic manifestations of exposure such that screening, surveillance and diagnostic procedures are able to detect and recognize autoimmune disease as a potential autoimmune outcome of asbestos exposure. Table 2 
